FDA Investigator Myra K Casey

Myra K Casey has inspections in 16 countries as of 03 Nov 2023. Myra K Casey has collaborated with a combinined 5285 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
334
Last Inspection Date:
03 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
100003584
Country:
United States of America, Hungary, Chile, Germany, France, Argentina, Japan, India, Netherlands, Italy, Australia, United Kingdom of Great Britain and Northern Ireland, Czechia, Taiwan, Spain
Co-Investigator(s):
Adam J Taylor, Adam S Freeman, Ademola O Daramola, Alanna Lmussawwir Bias, Allen F Hall, Allison E Sincek, Amanda M Dunneback, Amina Bashir, Amy S Graf, Andrace Lde Yampert, Andrea D Swingle, Andrew H Paeng, Angel K Sandhu, Angela E Glenn, Angela J Alexander, Ann Marie Montemurro, Ann Marie Schofield, Anthony R Petriella, Antionette N Johnson, Arindam Dasgupta, PhD, Azza Talaat, Barbara A Rusin, Barbara D Bennett, Barbara T Carmichael, Bei Y He, Benjamin J Dastoli, Benjamin J Smith, Bleta Vuniqi, Brandi N Mcgrady, Brandon Bridgman, Brentley S Collins, Brian J Mundo, Brian M Campbell, Brian P Putz, Brittany M Lowe, Bruce, Bruce D Meade, Byungja E Marciante, Calvin K Cook, Camille D Brown, Catherine V Quinlan, CDR Donald Ertel, CDR Kimberly Y Martin, Charles I Ann, Charles L Zhou, Charles M Spyr, Chelsea J Falkowski, Cheron M Portee, Christi L Bellmore, Christian D Lynch (CDL), Christina L Bigham, Christine A Harman, PhD, Clotia Cabbey Mensah, Comyar Shoghi, Constantin Y Philopoulos, Corrine M Carter, Courtney N Long, Crystal M Young Lewis, Cynthia Jim, CSO, Cynthia L Aycock, Cynthia L Kelley, Cynthia Li, Danial S Hutchison, Daniel J Brown, Danny Tuntevski, Darren S Morgan, David A Paterson, David E Bailey, David J Gasparovich, David L Duncan, Dawn C Olenjack, Dawnna D Brown, Debara R Reese, Debara Reese, Deborah M Trout, Denise L Burosh, Denise M Visco, Investigator, Dennis E Guilfoyle, PhD, Dennis R Hock, Dina A Tallman, Don A Leeseberg, Donald C Obenhuber, PhD, Dr. Gopa Biswas, PhD, Eliezar Ramos, Elizabeth J Rigoni, Emest F Bizjak, Emily J Orban, Emmanuel A Dimaano, Jr, Eric S Pittman, Erin M Miller, Erma Zaimova, French, Gabryelle J Solverud, Gene D Arcy, Gene R Gunn, Geneve M Maxwell, Geneve M Parks, Geneve Maxwell, George G Calafactor, Harperd, Helen B Ricalde, Hoimay Chan, Holly Brevig, Holly M Scott, Ifueko Osemwota, Ismael Olvera, IV, Jacob G Lutz, Jacqueline Mdiaz Albertini, James A Lane, James E Szelc, James K Ireland, Jana L Caylor, Janet L Bowen, Jean Blackston Hill, Jean Blackstone Hill, Jean Lhu Primmer, Jeanne F Broderick, Jeanne J Thai, Jeffrey A Sincek, Jeffrey A Sommers, Jeffrey D Meng, Jennifer A Kemp, Jennifer L Bridgewater, Joan A Loreng, Joan Johnson, Joel D Martinez, Jolanna A Norton, Joseph A Piechocki, Joseph R Strelnik, Joshua M Adams, Joshua S Hoeh, Judith A Jankowski, Juliane C Lessard, Julie D Bringger, Kaarin M Slotte, Karen M Montgomery (KMM), Kathryn G Brown, Kelley L Clark, Kennita Riddick, Kimberly A Dux, Kinh Q Mac, Kristina Mezin, Kyra K Casey, L Gnnmassimia Massimilla, PharmD, L'oreal F Walker, Larry K Austin, Laureen F Kononen, Laureen M Geniusz, Lauren E Sexton, Lauren Iacono Connors, PhD, LCDR Anastasia Mpiliafas Brown, LCDR Matthew J Morrison, LCDR Randall L Morris, Leigh Anne Myers, Leonard Pesetsky, Lesley Maep Lutao, Leslie A Paul, Lewis K Antwi, Linda S Jozefiak, Linda S Shook, Linda Thai, Lisa M Bellows, Lisa P Oakes, Lisa Pierce Oakes, Luella J Rossi, Maida Henesian (NMI), Maribeth G Grattan, Maribeth G Niesen, Mark C Saale, Marsha W Major, Martha Sullivan Myrick, Martin R Vowell, Matthew J Gretkierewicz, Meisha R Sampson, Meisha Waters, Melina Rodriguez Upton, Mercy Oyugi, Michael C Ireland, Michael F Skelly, PhD, Michael I Gorman, Michael Serrano, Michael Shanks, MS, Michele L Forster, PhD, Michele Perry Williams, Mihaly S Ligmond, Minerva Rogers, Mizanne E Lewis, Monica J Wilkins, Montgomery Montgomery, Karen M, Mpris Inspector, Muna Algharibeh, Nailing Zhang, Nancy A Bellamy, Nancy L Neiger, Natalie A Mickelsen, DVM, Neal D Singletary, PhD, Neali H Lucas, Nebil A Oumer, Nerizza B Guerin, Norman Wong, Omotunde O Osunsanmi, Patricia A Cochran, Patricia H Dlugosz, Patrick B Cummings, Patsy I Domingo, Patsy J Domingo, Paul A Licata, Paula A Trost, Peter E Baker, Peyton B Greenwood, Philip A Klimkewicz, Phillip M Pontikos, Prabhu P Raju, Qiao Y Bobo, Quynh H Strandberg, Rachel T Evans, Rafeeq A Habeeb, Ralph A Erickson, Raymond R Roy, PhD, Raymond T Oji, Rebecca E Dombrowski, Reginald Walker, Richard K Vogel, Richard T Riggie, Robert C Coleman, Robert D Tollefsen, Robert G Ruff, Robert J Ham, Robert M Barbosa, Robert R Barbosa, Roger F Zabinski, Ronald G Crawford, Ronnie E Jackson, Rosanna M Goodrich, Rose M Ashley, Rosia E Nesbitt, Ryan J Benedict, Saikat I Bhuiyan, Samantha J Pinizzotto, D V M, Sandra A Boyd, Sanket N Patel, Sarah E Rhoades, Sarah M Napier, Sargum C Sood, Schwierjohann Schwierjohann, Lindsey, Scott A Golladay, Sergio Chavez (NMI), Shannon A Gregory, Sherri J Jackson, Sparky L Bartee, State Agency, Stefen D Mcmillan, Stephanie Mangigian, MS/OSH, RN, Steven C Derrick, Stuart W Russell, Susan F Laska, MS, Susan M Jackson, Susan M Miller, Susan M North, Susan P Bruederle, Susanne M Richardson, MSc RAC ELS, Suyang Qin, Taichun Qin, PhD, Talmane J Fisher, Tania E Vizcaino, Terrance L Thomas, Theodore N Sietsema, Thomas A Peter, Thomas J Arista, Thomas J Cosgrove, Thomas R Beilke, Thuy T Nguyen, LCDR, Tiara Nbrown Crosen, Timothy C Grome, Tina M Pawlowski, Tonnie L Carter, Tracey Asinjen Wiersma, Tracey L Siebesma, Travis S Bradley, Uruaku A Obasi, Vesa Vuniqi, Victoria A Murray, Wayne E Seifert, William D Tingley, William G Nelson, William R Brubaker, Yangmin Ning, Young M Choi, PhD, Yumi J Hiramine, Yvins Dezan, Zoey A Trombley

Myra K Casey's Documents

Publish Date Document Type Title
February, 2016 FDA 483 Response James B. Harris, III, M.D. - Form 483R, 2016-02-18
September, 2016 EIR Cassandra E. Curtis, M.D. - EIR, 2016-09-14
March, 2020 EIR Eli Lilly and Company - EIR, 2020-03-20
March, 2001 FDA 483 Pharmacia & Upjohn Company LLC - Form 483, 2001-03-22
April, 2018 EIR Eli Lilly and Company - EIR, 2018-04-23
September, 2013 EIR Pattanam D. Srinivasan, MD - EIR, 2013-09-27
February, 2005 FDA 483 Biomet, Inc. - Form 483, 2005-02-24
October, 2009 FDA 483 JBS United, Inc. - Form 483, 2009-10-07
April, 2018 FDA 483 Eli Lilly and Company - Form 483, 2018-04-23
June, 2019 FDA 483 Roche Diagnostics Operations, Inc. - Form 483, 2019-06-27
May, 2019 FDA 483 Shadia I. Jalal, M.D. - Form 483, 2019-05-17
July, 2010 FDA 483 American Red Cross Blood Svs. Indiana-Ohio Region - Form 483, 2010-07-21
September, 2013 FDA 483 Pattanam D. Srinivasan, MD - Form 483, 2013-09-27
June, 2018 FDA 483 Peter Nasveld, M.D. - Form 483, 2018-06-01
July, 2016 FDA 483 Response David A. Plager, M.D. - Form 483R, 2016-08-12
December, 2018 FDA 483 Merrill D. Benson, M.D. - Form 483, 2018-12-03
July, 2021 FDA 483 Blair M. Brengle, M.D. - Form 483, 2021-07-08
May, 2014 EIR Eli Lilly and Company - EIR, 2014-05-08
November, 2016 FDA 483 Response Merrill D. Benson, M.D. - Form 483R, 2016-11-30
February, 2017 EIR Roche Molecular Systems, Inc. - EIR, 2017-02-27
January, 2013 EIR Bio-Blood Components, Inc. - EIR, 2013-01-16
November, 2016 FDA 483 Merrill D. Benson, M.D. - Form 483, 2016-11-10
April, 2012 FDA 483 Response Memorial Hospital Of South Bend, IRB - Form 483R, 2012-04-23
October, 2017 FDA 483 Response Institutional Review Board of Franciscan Health Lafayette - Form 483R, 2017-10-31
September, 2009 FDA 483 South Bend Medical Foundation, Inc. - Form 483, 2009-09-11
January, 2003 EIR Hood, Ricardo, MD - EIR, 2003-01-27
February, 2016 FDA 483 James B. Harris, III, M.D. - Form 483, 2016-02-05
January, 2013 FDA 483 Bio-Blood Components, Inc. - Form 483, 2013-01-16
September, 2019 FDA 483 Scott T. Guenthner M.D. - Form 483, 2019-09-26
October, 2017 EIR Institutional Review Board of Franciscan Health Lafayette - EIR, 2017-10-18
November, 2016 EIR Merrill D. Benson, M.D. - EIR, 2016-11-10
July, 2008 FDA 483 Biomet, Inc. - Form 483, 2008-07-15
June, 2009 FDA 483 Versiti Indiana Inc - Form 483, 2009-06-18
March, 2014 FDA 483 Ann Greist, MD - Form 483, 2014-03-17
September, 2016 FDA 483 Cassandra E. Curtis, M.D. - Form 483, 2016-09-14
February, 2020 FDA 483 Indiana University IRB - Form 483, 2020-02-14
December, 2014 FDA 483 Institutional Review Board of Franciscan Health Lafayette - Form 483, 2014-12-03
March, 2010 FDA 483 Donor Services of Indiana, Inc. - Form 483, 2010-03-29
September, 2013 FDA 483 Response Pattanam D. Srinivasan, MD - Form 483R, 2013-10-18
September, 2018 FDA 483 Sandeep Batra, MD - Form 483, 2018-10-02
January, 2020 EIR Eli Lilly and Company - EIR, 2020-01-17
December, 2015 EIR Covance Clinical Research Unit, Inc. - EIR, 2015-12-04
March, 2001 FDA 483 Response Pharmacia & Upjohn Company LLC - Form 483R, 2001-04-02
November, 2012 EIR Goshen Hospital IRB - EIR, 2012-11-06
July, 2016 FDA 483 David A. Plager, M.D. - Form 483, 2016-07-27
April, 2012 FDA 483 Memorial Hospital Of South Bend, IRB - Form 483, 2012-04-23
August, 2019 EIR Esperion - EIR, 2019-08-09
February, 2016 EIR Concentrics Research, LLC - EIR, 2016-02-24
September, 2002 FDA 483 Emergent Biodefense Operations Lansing LLC - Form 483, 2002-09-13
September, 2016 FDA 483 Response Cassandra E. Curtis, M.D. - Form 483R, 2016-10-04
March, 2001 EIR Pharmacia & Upjohn Company LLC - EIR, 2001-03-22
September, 2002 FDA 483 Response Emergent Biodefense Operations Lansing LLC - Form 483R, 2002-10-07
October, 2004 EIR Access Business Group LLC - EIR, 2004-10-19
October, 2017 FDA 483 Institutional Review Board of Franciscan Health Lafayette - Form 483, 2017-10-18
January, 2003 FDA 483 Hood, Ricardo, MD - Form 483, 2003-01-27
December, 2014 FDA 483 Response Institutional Review Board of Franciscan Health Lafayette - Form 483R, 2014-12-22
February, 2008 EIR DePuy Orthopaedics, Inc. - EIR, 2008-02-11
March, 2019 FDA 483 WR-MCCR, LLC - Form 483, 2019-03-12
December, 2013 FDA 483 Eli Lilly and Company - Form 483, 2013-12-06
April, 2012 EIR Memorial Hospital Of South Bend, IRB - EIR, 2012-04-23
August, 2019 FDA 483 Esperion - Form 483, 2019-08-09
September, 2017 FDA 483 Michael E. Berend, M.D. - Form 483, 2017-09-19
March, 2018 FDA 483 Joseph M.B. Croffie, MD - Form 483, 2018-03-16
July, 2016 EIR David A. Plager, M.D. - EIR, 2016-07-27
February, 2013 FDA 483 Veterans Affairs Medical Center - Form 483, 2013-02-20
August, 2001 EIR Rudolph M. Navari M.D. - EIR, 2001-08-14
August, 2001 FDA 483 SouthBend Clinic - Form 483, 2001-08-14

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more